Published in Gastroenterol Rep (Oxf) on June 14, 2013
Hepatocellular carcinoma. Lancet (2003) 22.54
Current strategy for staging and treatment: the BCLC update and future prospects. Semin Liver Dis (2010) 5.85
The international position on laparoscopic liver surgery: The Louisville Statement, 2008. Ann Surg (2009) 5.33
Neither multiple tumors nor portal hypertension are surgical contraindications for hepatocellular carcinoma. Gastroenterology (2008) 4.61
Partial hepatectomy with wide versus narrow resection margin for solitary hepatocellular carcinoma: a prospective randomized trial. Ann Surg (2007) 2.53
Laparoscopic liver resection facilitates salvage liver transplantation for hepatocellular carcinoma. J Hepatobiliary Pancreat Surg (2009) 2.12
Laparoscopic hepatectomy for hepatocellular carcinoma: a European experience. J Am Coll Surg (2010) 2.05
Comparison of the outcomes between an anatomical subsegmentectomy and a non-anatomical minor hepatectomy for single hepatocellular carcinomas based on a Japanese nationwide survey. Surgery (2008) 2.04
A system of classifying microvascular invasion to predict outcome after resection in patients with hepatocellular carcinoma. Gastroenterology (2009) 1.90
Spontaneous tumour rupture and prognosis in patients with hepatocellular carcinoma. Br J Surg (2002) 1.53
Neoadjuvant and adjuvant therapy for resectable hepatocellular carcinoma: review of the randomised clinical trials. Lancet Oncol (2002) 1.52
Resection of hepatocellular carcinoma in patients without cirrhosis. Br J Surg (2011) 1.48
Efficacy of anatomic resection vs nonanatomic resection for small nodular hepatocellular carcinoma based on gross classification. J Hepatobiliary Pancreat Surg (2008) 1.17
The surgical approach to HCC: our progress and results in Japan. Liver Transpl (2004) 1.15
Surgical strategies for hepatocellular carcinoma with special reference to anatomical hepatic resection and intraoperative contrast-enhanced ultrasonography. Oncology (2010) 1.14
Results of hepatic resection for hepatocellular carcinoma invading major portal and/or hepatic veins. Surg Oncol Clin N Am (2003) 1.11
Recurrence-free survival more than 10 years after liver resection for hepatocellular carcinoma. Br J Surg (2011) 1.01
Inhibition of interleukin-6-activated janus kinases/signal transducers and activators of transcription but not mitogen-activated protein kinase signaling in liver of endotoxin-treated rats. Crit Care Med (2002) 1.45
A pilot programme of organ donation after cardiac death in China. Lancet (2011) 1.39
Voluntary organ donation system adapted to Chinese cultural values and social reality. Liver Transpl (2015) 1.23
Primary liver cancer presenting as pyogenic liver abscess: characteristics, diagnosis, and management. J Surg Oncol (2011) 1.22
Government policy and organ transplantation in China. Lancet (2008) 1.20
Increased Golgi protein 73 expression in hepatocellular carcinoma tissue correlates with tumor aggression but not survival. J Gastroenterol Hepatol (2011) 1.13
Hepatobiliary cystadenomas and cystadenocarcinomas: a report of 33 cases. Liver Int (2011) 1.02
A novel liver function evaluation system using radiopharmacokinetic modeling of technetium-99m-DTPA-galactosyl human serum albumin. Nucl Med Commun (2013) 0.97
A prospective clinical study on early recurrence of hepatocellular carcinoma after hepatectomy. J Surg Oncol (2009) 0.94
Golgi protein 73, not Glypican-3, may be a tumor marker complementary to α-Fetoprotein for hepatocellular carcinoma diagnosis. J Gastroenterol Hepatol (2014) 0.93
Value of quantitative and qualitative analyses of circulating cell-free DNA as diagnostic tools for hepatocellular carcinoma: a meta-analysis. Medicine (Baltimore) (2015) 0.88
Prognostic factors after liver resection for hepatocellular carcinoma: a single-center experience from China. Am J Surg (2011) 0.87
The effects of urinary trypsin inhibitor on liver function and inflammatory factors in patients undergoing hepatectomy: a prospective, randomized, controlled clinical study. Am J Surg (2011) 0.84
Prediction and identification of tumor-specific noncoding RNAs from human UniGene. Med Oncol (2009) 0.81
Effect of tomato extract supplementation against high-fat diet-induced hepatic lesions. Hepatobiliary Surg Nutr (2013) 0.80
Aggressive Locoregional Treatment Improves the Outcome of Liver Metastases from Grade 3 Gastroenteropancreatic Neuroendocrine Tumors. Medicine (Baltimore) (2015) 0.79
Retrospective and comparative study of inflammatory myofibroblastic tumor of the liver. J Gastroenterol Hepatol (2015) 0.78
Surgical resection improves the outcome of the patients with neuroendocrine tumor liver metastases: large data from Asia. Medicine (Baltimore) (2015) 0.78
Improving evaluation of primary gastric malignancies by distending the stomach with milk immediately before 18F-FDG PET scanning. J Nucl Med Technol (2008) 0.76
Differential Diagnosis of Immunoglobulin G4-associated Cholangitis From Cholangiocarcinoma. J Clin Gastroenterol (2016) 0.76
Spontaneous rupture of a giant hepatobiliary serous cystadenoma: report of a case and literature review. Hepatol Int (2010) 0.75
Clinical diagnosis and treatment of alpha-fetoprotein-negative small hepatic lesions. Chin J Cancer Res (2013) 0.75
Multiple Primary Malignancies in Patients With Hepatocellular Carcinoma: A Largest Series With 26-Year Follow-Up. Medicine (Baltimore) (2016) 0.75
The diagnostic value of assays for circulating tumor cells in hepatocellular carcinoma: A meta-analysis. Medicine (Baltimore) (2017) 0.75
Hepatitis B virus promotes autophagic degradation but not replication in autophagosome. Biosci Trends (2015) 0.75
Modernization of the organ transplantation program in China. Transplantation (2008) 0.75
Bleeding ectopics. Lancet (2010) 0.75